J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

IMMEDIATE OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Free Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Odds, F. C.
Right arrow Articles by Jones, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Odds, F. C.
Right arrow Articles by Jones, B. L.
Agricola
Right arrow Articles by Odds, F. C.
Right arrow Articles by Jones, B. L.
J Med Microbiol 56 (2007), 1066-1075; DOI: 10.1099/jmm.0.47239-0
© 2007 Society for General Microbiology
ISSN 1473-5644

One year prospective survey of Candida bloodstream infections in Scotland

Frank C. Odds1, Mary F. Hanson2, Amanda D. Davidson1, Mette D. Jacobsen1, Pauline Wright3, Julie A. Whyte1, Neil A. R. Gow1 and Brian L. Jones3

1 Aberdeen Fungal Group, School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK

2 Department of Medical Microbiology, Western General Hospital, Edinburgh EH4 10XU, UK

3 Department of Medical Microbiology, Royal Infirmary, Glasgow G4 OSF, UK

Correspondence
Frank C. Odds
f.odds{at}abdn.ac.uk

Received 19 February 2007
Accepted 13 April 2007

A 12 month survey of candidaemia in Scotland, UK, in which every Scottish hospital laboratory submitted all blood isolates of yeasts for identification, strain typing and susceptibility testing, provided 300 isolates from 242 patients, generating incidence data of 4.8 cases per 100 000 population per year and 5.9 cases per 100 000 acute occupied bed days; 27.9 % of cases occurred in intensive care units. More than half the patients with candidaemia had an underlying disease involving the abdomen, 78 % had an indwelling intravenous catheter, 62 % had suffered a bacterial infection within the 2 weeks prior to candidaemia and 37 % had undergone a laparotomy. Candida albicans was the infecting species in 50 % of cases, followed by Candida glabrata (21 %) and Candida parapsilosis (12 %). Seven cases of candidaemia were caused by Candida dubliniensis, which was more prevalent even than Candida lusitaniae and Candida tropicalis (six cases each). Among C. glabrata isolates, 55 % showed reduced susceptibility to fluconazole, but azole resistance among other species was extremely low. Multilocus sequence typing showed isolates with high similarity came from different hospitals across the country, and many different types came from the hospitals that submitted the most isolates, indicating no tendency towards hospital-specific endemic strains. Multiple isolates of C. albicans and C. glabrata from individual patients were of the same strain type with single exceptions for each species. The high prevalence of candidaemia in Scotland, relative to other population-based European studies, and the high level of reduced fluconazole susceptibility of Scottish C. glabrata isolates warrant continued future surveillance of invasive Candida infections.

Abbreviations: AOBD, acute occupied bed day; DST, diploid sequence type; ICU, intensive care unit; IV, intravenous; MLST, multilocus sequence typing; OBD, occupied bed day; PMN, polymorphonuclear neutrophil; S-DD, susceptible dose-dependent; ST, sequence type.




This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
M. C. Arendrup, G. Garcia-Effron, W. Buzina, K. L. Mortensen, N. Reiter, C. Lundin, H. E. Jensen, C. Lass-Florl, D. S. Perlin, and B. Bruun
Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing
Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1185 - 1193.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Tumbarello, M. Sanguinetti, E. M. Trecarichi, M. La Sorda, M. Rossi, E. de Carolis, K. de Gaetano Donati, G. Fadda, R. Cauda, and B. Posteraro
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome
J. Antimicrob. Chemother., December 1, 2008; 62(6): 1379 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. R. Lockhart, S. A. Messer, M. A. Pfaller, and D. J. Diekema
Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis
J. Clin. Microbiol., August 1, 2008; 46(8): 2659 - 2664.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
F. C. Odds and M. D. Jacobsen
Multilocus Sequence Typing of Pathogenic Candida Species
Eukaryot. Cell, July 1, 2008; 7(7): 1075 - 1084.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2007 Society for General Microbiology.